Agilis Biotherapeutics and Gene Therapy Research Institution Enter into Strategic Partnership – Business Wire (press release)
|
Agilis Biotherapeutics and Gene Therapy Research Institution Enter into Strategic Partnership
Business Wire (press release) CAMBRIDGE, Mass. & TOKYO–(BUSINESS WIRE)–Agilis Biotherapeutics, Inc. (Agilis), a biotechnology company advancing innovative DNA therapeutics for rare genetic diseases that affect the central nervous system (CNS), and Gene Therapy Research … |
